Drugs / Bone marrow mesenchymal stem cells
Bone marrow mesenchymal stem cells
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02985346 | Jan 2017 → Dec 2020 | pulmonary hemosiderosis | Sun Yat-sen University | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02594839 | Feb 2013 → Jan 2018 | idiopathic pulmonary fibrosis | Federal Research Clinical Center of Federal Medical & Biological Agency, Russia | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT05027581 | Oct 2021 → Dec 2023 | osteoarthritis, knee | Taiwan Bio Therapeutics Inc. | Completed | No outcome recorded |
| Phase 2 | NCT03047772 | Mar → Dec 2018 | myocardial infarction | Yuejin Yang | Unknown | No outcome recorded |
| Phase 2/31 trial · 1 missed | ||||||
| Phase 2/3 | NCT04421274 | May 2008 → Jul 2010 | myocardial infarction | Affiliated Hospital of North Sichuan Medical College | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04351932 Comparator | Jun 2020 → Jun 2021 | osteoarthritis, knee | Universidad Catolica Santiago de Guayaquil | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow mesenchymal stem cells | “intracoronary infusion of autologous bone marrow mesenchymal stem cells (MSCINJ) in combination with intensive atorvastatin (ATV) treatment” PMID 31829095 ↗ Dec 2019 |
| Known as | BM-MSC | “Bone marrow mesenchymal stem cells (BM-MSC) and adipose derived mesenchymal stem cells (AD-MSC) have been used separately to treat OA.” NCT04351932 ↗ |
| Known as | BM-MSCs | “To investigate the safety of intra-coronary injection of autologous bone marrow mesenchymal stem cells (BM-MSCs) in patients with ST-segment elevation myocardial infarction and...” NCT04421274 ↗ |
| Known as | BMSC | “Bone marrow mesenchymal stem cells (BMSC) are a kind of adult stem cells with high self-renewal and multi-directional differentiation potential in bone marrow.” NCT02985346 ↗ |
| Known as | MSCINJ | “intracoronary infusion of autologous bone marrow mesenchymal stem cells (MSCINJ) in combination with intensive atorvastatin (ATV) treatment” PMID 31829095 ↗ Dec 2019 |
| Modality | Cell therapy | “The transplantation of allogeneic stem cells is a promising direction in the modern medicine” NCT02594839 ↗ |
| Route | Intravenous | “2 intravenous infusions of suspension of 200 000 000 MSCs each at interval of 7 days” NCT02594839 ↗ |